3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
22
Observational
2
Sponsor
Cancer Type
Breast
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
19
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
9
Pancreatic Neoplasms
8
Neoplasms
8
Colorectal Neoplasms
8
Melanoma
6
Colonic Neoplasms
6
Esophageal Neoplasms
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Precancerous Conditions
4
Myelodysplastic Syndromes
4
Lymphoma
4
Lung Neoplasms
4
Liver Neoplasms
4
Head and Neck Neoplasms
4
Barrett Esophagus
4
Squamous Cell Carcinoma of Head and Neck
3
Salivary Gland Neoplasms
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Mouth Neoplasms
3
Kidney Neoplasms
3
Gastrointestinal Neoplasms
3
Gastroesophageal Reflux
3
Gastritis, Atrophic
3
Adenocarcinoma Of Esophagus
3
Uterine Cervical Neoplasms
2
Interventions
Blood Specimen Collection
5
Drug Therapy
3
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Carboplatin
2
Biopsy, Large-Core Needle
2
Biopsy
2
toripalimab
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
atezolizumab
1
Zoledronic Acid
1
Urine Specimen Collection
1
Prophylactic Mastectomy
1
Paracentesis
1
Neuropsychological Tests
1
Mifepristone
1
Medicine, Chinese Traditional
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Doxorubicin
1
DNA
1
Cyclophosphamide
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Biopsy
×
Clear all
NCT07327489
2026-01-08
ELEPHAS-05
Elephas
Recruiting
2,000 enrolled
NCT06182306
2024-04-03
PEAR-MET
Ourotech, Inc.
Recruiting
30 enrolled